{"log_id": 7924486855697261809, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 0, "average": 0.999684, "min": 0.999072}, "location": {"width": 79, "top": 249, "height": 31, "left": 210}, "words": "【禁忌】"}, {"probability": {"variance": 0.000788, "average": 0.989159, "min": 0.905082}, "location": {"width": 223, "top": 293, "height": 29, "left": 249}, "words": "对阿糖胞苷过敏者禁用"}, {"probability": {"variance": 0, "average": 0.999743, "min": 0.998933}, "location": {"width": 121, "top": 381, "height": 27, "left": 214}, "words": "【注意事项】"}, {"probability": {"variance": 3e-06, "average": 0.998632, "min": 0.992233}, "location": {"width": 456, "top": 416, "height": 38, "left": 250}, "words": "本品使用苯甲醇作为溶媒,禁用于儿童肌肉注射"}, {"probability": {"variance": 1.9e-05, "average": 0.99835, "min": 0.979322}, "location": {"width": 461, "top": 461, "height": 35, "left": 250}, "words": "只有对肿瘤化疗有经验的医生才可使用阿糖胞苷"}, {"probability": {"variance": 1e-06, "average": 0.99921, "min": 0.995365}, "location": {"width": 720, "top": 500, "height": 38, "left": 252}, "words": "患者在诱导治疗时,应有足够的实验室和辅助设备以监测患者对药物的耐受"}, {"probability": {"variance": 0.001237, "average": 0.993198, "min": 0.785357}, "location": {"width": 786, "top": 542, "height": 39, "left": 208}, "words": "性,确保患者免遭药物的毒性损害。阿糖胞苷的主要毒性反应是骨髓抑制,表现为"}, {"probability": {"variance": 8e-06, "average": 0.998874, "min": 0.98483}, "location": {"width": 782, "top": 585, "height": 38, "left": 210}, "words": "白细胞减少、血小板减少和贫血。程度较轻的毒性反应包括恶心、呕吐、腹泻和腹"}, {"probability": {"variance": 1e-06, "average": 0.999481, "min": 0.995457}, "location": {"width": 287, "top": 632, "height": 32, "left": 209}, "words": "痛、口腔溃疡以及肝功能异常"}, {"probability": {"variance": 1e-06, "average": 0.99938, "min": 0.993552}, "location": {"width": 742, "top": 669, "height": 38, "left": 253}, "words": "在考虑应用本品治疗时,医生必须考虑药物可能的疗效和其毒性反应。在考虑"}, {"probability": {"variance": 0, "average": 0.999676, "min": 0.99892}, "location": {"width": 416, "top": 717, "height": 32, "left": 211}, "words": "应用或开始使用时,医生必须熟悉下列内容"}, {"probability": {"variance": 3e-06, "average": 0.998295, "min": 0.995199}, "location": {"width": 176, "top": 764, "height": 26, "left": 214}, "words": "对血液系统的影响"}, {"probability": {"variance": 1e-06, "average": 0.999353, "min": 0.995348}, "location": {"width": 742, "top": 797, "height": 37, "left": 254}, "words": "阿糖胞苷是一种强效的骨髓抑制剂。骨髓抑制的严重程度取决于用药的剂量以"}, {"probability": {"variance": 1.6e-05, "average": 0.998029, "min": 0.979513}, "location": {"width": 786, "top": 839, "height": 39, "left": 211}, "words": "及用药方案。对既往药物已引起骨髓抑制的患者必须谨慎地开始用药。患者用药时"}, {"probability": {"variance": 3.3e-05, "average": 0.997561, "min": 0.972648}, "location": {"width": 786, "top": 882, "height": 39, "left": 211}, "words": "必须接受密切的医疗监护,在诱导治疗时,须每天检测白细胞和血小板计数。在周"}, {"probability": {"variance": 1e-06, "average": 0.999096, "min": 0.994146}, "location": {"width": 783, "top": 925, "height": 39, "left": 214}, "words": "围血象原始细胞消失后,需经常进行骨髓检查。当药物引起骨髓抑制使血小板计数"}, {"probability": {"variance": 0.001482, "average": 0.978051, "min": 0.817375}, "location": {"width": 432, "top": 971, "height": 35, "left": 212}, "words": "低于50,000/m3或多核粒细胞计数低于1000"}, {"probability": {"variance": 0, "average": 0.999627, "min": 0.998962}, "location": {"width": 282, "top": 970, "height": 26, "left": 690}, "words": "时,应考虑停药或更改治疗方"}, {"probability": {"variance": 3.4e-05, "average": 0.996851, "min": 0.970392}, "location": {"width": 753, "top": 1010, "height": 38, "left": 212}, "words": "案。外周血有形成份计数在停药后可能进一步降低,在停药后12-24天达最低"}, {"probability": {"variance": 1e-06, "average": 0.999518, "min": 0.995698}, "location": {"width": 787, "top": 1052, "height": 39, "left": 212}, "words": "值。需要时,当有确切骨髓恢复的表现时,可再次开始治疗。必须具备处理可能导"}, {"probability": {"variance": 5e-06, "average": 0.998588, "min": 0.990164}, "location": {"width": 786, "top": 1095, "height": 37, "left": 212}, "words": "致死亡的骨髓抑制(粒细胞减少和其他机体防御功能受损所致的感染和血小板减少"}, {"probability": {"variance": 2e-06, "average": 0.997801, "min": 0.995107}, "location": {"width": 196, "top": 1146, "height": 27, "left": 214}, "words": "所致的出血)的条件"}, {"probability": {"variance": 1.1e-05, "average": 0.998909, "min": 0.981714}, "location": {"width": 743, "top": 1181, "height": 36, "left": 257}, "words": "阿糖胞苷治疗曾发生过敏反应。有过敏反应导致心跳呼吸骤停,并需心肺复苏"}, {"probability": {"variance": 8e-06, "average": 0.998474, "min": 0.989447}, "location": {"width": 482, "top": 1225, "height": 36, "left": 215}, "words": "的报道。上述情况在静脉给予阿糖胞苷后立即发生"}, {"probability": {"variance": 1.4e-05, "average": 0.997374, "min": 0.990028}, "location": {"width": 111, "top": 1276, "height": 26, "left": 218}, "words": "大剂量方案"}, {"probability": {"variance": 0.005592, "average": 0.588406, "min": 0.513625}, "location": {"width": 68, "top": 1282, "height": 35, "left": 839}, "words": "基分"}, {"probability": {"variance": 0.00224, "average": 0.980685, "min": 0.745019}, "location": {"width": 724, "top": 1304, "height": 47, "left": 258}, "words": "有报道阿糖胞苷大剂量(2-3gm2)治疗后可发生严重的、基至是致命的"}, {"probability": {"variance": 2.8e-05, "average": 0.996999, "min": 0.973116}, "location": {"width": 768, "top": 1348, "height": 42, "left": 214}, "words": "神经系统、胃肠道和肺部毒性反应(不同于阿糖胞苷常规方案治疗引起的毒性反"}, {"probability": {"variance": 1.1e-05, "average": 0.998417, "min": 0.980741}, "location": {"width": 778, "top": 1393, "height": 37, "left": 218}, "words": "应)。这些反应包括可逆的角膜毒性和出血性结膜炎,预防性局部应用类固醇滴眼"}, {"probability": {"variance": 0.000903, "average": 0.991704, "min": 0.827815}, "location": {"width": 765, "top": 1430, "height": 50, "left": 217}, "words": "剂能预防或减轻症状:大脑和小脑功能失调,包括人格改变嗜睡、惊厥和昏迷"}, {"probability": {"variance": 4e-06, "average": 0.998146, "min": 0.994311}, "location": {"width": 126, "top": 1499, "height": 24, "left": 553}, "words": "第9页,共16页"}, {"probability": {"variance": 0, "average": 0.996883, "min": 0.996247}, "location": {"width": 17, "top": 1526, "height": 18, "left": 301}, "words": "20"}], "language": 3}